102 related articles for article (PubMed ID: 1563533)
1. [Immunointervention in type 1 diabetes mellitus].
Vialettes B
Diabete Metab; 1992; 18(1):3-10; discussion 11-3. PubMed ID: 1563533
[No Abstract] [Full Text] [Related]
2. Outlook for immune intervention in type I diabetes.
Grob PJ
Curr Probl Clin Biochem; 1983; 12():119-40. PubMed ID: 6360542
[No Abstract] [Full Text] [Related]
3. Immune intervention in type I diabetes mellitus--current clinical and experimental approaches.
Kolb H
Exp Clin Endocrinol; 1994; 102(4):269-72. PubMed ID: 7813597
[TBL] [Abstract][Full Text] [Related]
4. [Immune modulation therapy in type I diabetes mellitus].
Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
[No Abstract] [Full Text] [Related]
5. Immunotherapy in type 1 diabetes.
Pozzilli P
Diabet Med; 1988 Nov; 5(8):734-8. PubMed ID: 2975564
[No Abstract] [Full Text] [Related]
6. [Specific features of cellular immunity of pulmonary tuberculosis in patients with diabetes mellitus].
Karachunskiĭ MA; Gergert VIa; Iakovleva OB
Probl Tuberk; 1997; (6):59-60. PubMed ID: 9503939
[TBL] [Abstract][Full Text] [Related]
7. [Immunotherapy of recent-onset type I diabetes mellitus].
Assan R
Ann Med Interne (Paris); 1985; 136(6):451-2. PubMed ID: 4083634
[No Abstract] [Full Text] [Related]
8. Tackling type 1 diabetes: new immune-modulating drugs attack the root cause.
Shekhar C
Chem Biol; 2007 Dec; 14(12):1305-6. PubMed ID: 18096495
[No Abstract] [Full Text] [Related]
9. [Principles and perspectives of immunomodulation in the treatment of diabetes mellitus type I].
Majkowska L; Czekalski S
Pol Tyg Lek; 1989 May 22-29; 44(21-22):509-12. PubMed ID: 2702343
[No Abstract] [Full Text] [Related]
10. [The characteristics of the immunogenesis and immunocorrection of diabetes mellitus].
Galenok VA; Zhuk EA
Ter Arkh; 1995; 67(10):7-12. PubMed ID: 8779114
[TBL] [Abstract][Full Text] [Related]
11. Innovative immune-based therapeutic approaches for the treatment of type 1 diabetes mellitus.
Eldor R; Cohen IR; Raz I
Int Rev Immunol; 2005; 24(5-6):327-39. PubMed ID: 16318985
[TBL] [Abstract][Full Text] [Related]
12. The pathogenesis, prediction, and prevention of insulin-dependent diabetes mellitus.
Muir A; Schatz DA; Maclaren NK
Endocrinol Metab Clin North Am; 1992 Jun; 21(2):199-219. PubMed ID: 1612064
[TBL] [Abstract][Full Text] [Related]
13. [Immunomodulating therapy in insulin-dependent diabetes mellitus: problems and new prospects].
Galenok VA; Zhuk EA
Ter Arkh; 1995; 67(12):80-4. PubMed ID: 8820069
[No Abstract] [Full Text] [Related]
14. [Immunotherapy in type 1 (insulin-dependent) diabetes].
Galluzzo A
Recenti Prog Med; 1984 Oct; 75(10):936-43. PubMed ID: 6083588
[No Abstract] [Full Text] [Related]
15. Immunotherapy of insulin-dependent diabetes.
Bell DS; Acton RT
Ala J Med Sci; 1985 Jul; 22(3):311-4. PubMed ID: 4025722
[No Abstract] [Full Text] [Related]
16. [Immunointervention in newly diagnosed type 1 diabetes].
Kaupper T; Walter M; Ziegler AG
Dtsch Med Wochenschr; 2006 Dec; 131(49):2783-8. PubMed ID: 17136660
[No Abstract] [Full Text] [Related]
17. The role of immunotherapy in type I diabetes mellitus.
Geffner ME; Lippe BM
West J Med; 1987 Mar; 146(3):337-43. PubMed ID: 3554759
[TBL] [Abstract][Full Text] [Related]
18. [Does the current knowledge on the pathogenesis of type 1 diabetes justify immunotherapeutic intervention?].
Pozzilli P; Signore A; Andreani D
Recenti Prog Med; 1986 May; 77(5):245-8. PubMed ID: 3526461
[No Abstract] [Full Text] [Related]
19. Type 1 diabetes immunotherapy: is the glass half empty or half full?
Herold KC; Bluestone JA
Sci Transl Med; 2011 Aug; 3(95):95fs1. PubMed ID: 21832236
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificity.
Bach JF; Chatenoud L
Chem Immunol; 1995; 60():32-47. PubMed ID: 7531979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
